ICD-10 Code A31.2 | Dissem mycobacterium avium-intracellulare complex (DMAC) Symptoms, Diagnosis, Billing

Disseminated Mycobacterium avium-intracellulare complex (DMAC) is a chronic infection caused by non-tuberculous mycobacteria, primarily affecting immunocompromised individuals. It is clinically significant due to its association with advanced HIV/AIDS and other immunosuppressive conditions. Accurate coding with ICD-10 Code A31.2 facilitates precise diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate management and resource allocation.

What is ICD-10 Code A31.2 for Dissem mycobacterium avium-intracellulare complex (DMAC)?

ICD-10 Code A31.2 represents Disseminated Mycobacterium avium-intracellulare complex (DMAC), a condition characterized by the widespread presence of mycobacteria in the body, often in patients with weakened immune systems. This code should be used in clinical documentation and billing when diagnosing patients with confirmed or suspected DMAC, particularly in the context of HIV/AIDS or other immunocompromising conditions.

ICD-10 Code A31.2 – Clinical Definition and Explanation of Dissem mycobacterium avium-intracellulare complex (DMAC)

Disseminated Mycobacterium avium-intracellulare complex (DMAC) is primarily caused by Mycobacterium avium and Mycobacterium intracellulare, which are opportunistic pathogens. The condition progresses insidiously, often leading to severe systemic illness in immunocompromised patients. Prompt medical attention is crucial to manage symptoms and prevent complications.

Key Clinical Features:

• Commonly presents with fever, weight loss, and night sweats.
• Often associated with advanced HIV/AIDS and other immunosuppressive states.
• Diagnosis typically involves culture of blood or other body fluids.
• May lead to disseminated disease affecting multiple organ systems.

ICD-10 Code A31.2 for Dissem mycobacterium avium-intracellulare complex (DMAC) – SOAP Notes & Clinical Use

ICD-10 Code A31.2 is utilized in SOAP notes to document the presence of DMAC, aiding in the assessment of symptoms, clinical findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code A31.2 for Dissem mycobacterium avium-intracellulare complex (DMAC) Mean in SOAP Notes?

In SOAP notes, ICD-10 Code A31.2 connects subjective patient reports and objective clinical findings to a formal diagnosis of DMAC. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code A31.2 – Dissem mycobacterium avium-intracellulare complex (DMAC)

Management of Disseminated Mycobacterium avium-intracellulare complex (DMAC) often requires hospitalization due to the severity of the condition. Treatment typically involves antibiotic therapy and supportive care.

Antibiotic Therapy:

• First-line: Azithromycin or Clarithromycin, typically for 12 months.
• Alternative: Rifabutin or Ethambutol may be considered based on susceptibility.
• Combination therapy is often recommended to prevent resistance.

Supportive Care:

• Nutritional support to address weight loss and malnutrition.
• Management of symptoms such as fever and malaise.
• Monitoring for potential complications, including organ dysfunction.

Infection Control:

• Implement standard precautions to prevent transmission.
• Educate patients on hygiene practices to reduce infection risk.
• Consider isolation measures in cases of severe immunosuppression.

How to Document Symptoms of Dissem mycobacterium avium-intracellulare complex (DMAC) (ICD-10 A31.2) in SOAP Notes

Subjective:

• Patient reports persistent fever and night sweats.
• History of significant weight loss over the past month.
• Complaints of fatigue and generalized malaise.
• Known HIV-positive status with recent CD4 count decline.

Objective:

• Vital signs: Fever of 101°F, tachycardia noted.
• Physical exam reveals lymphadenopathy and hepatomegaly.
• Laboratory findings: Positive blood cultures for Mycobacterium avium.
• Imaging may show pulmonary nodules or infiltrates.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Dissem mycobacterium avium-intracellulare complex (DMAC) (ICD-10 Code A31.2)

Assessment:

• Diagnosis: Disseminated Mycobacterium avium-intracellulare complex (DMAC), severe.
• ICD-10 Code: A31.2.
• Contributing factors: Advanced HIV/AIDS with CD4 count < 200.
• Consider potential complications such as organ failure.

Plan:

• Initiate antibiotic therapy with Azithromycin and monitor response.
• Provide nutritional support and manage symptoms.
• Schedule follow-up in 1 month to reassess clinical status.
• Educate patient on infection control measures.

Treatment & Plan Section for ICD-10 Code A31.2 – Dissem mycobacterium avium-intracellulare complex (DMAC)

• First-line pharmacologic treatment includes Azithromycin or Clarithromycin.
• Non-pharmacologic strategies involve nutritional support and symptom management.
• Monitoring includes regular follow-up appointments and laboratory tests.
• Educate patients on the importance of adherence to therapy and infection control.

Using ICD-10 Code A31.2 for Dissem mycobacterium avium-intracellulare complex (DMAC) in Billing & SOAP Note Compliance

• Select accurate subcodes based on clinical severity or complications.
• Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
• Ensure treatment plans align with clinical guidelines to support justified billing.
• Only list CPT codes that are commonly billed with ICD-10 Code A31.2 based on standard medical coding practices.

Related ICD-10 Codes Often Used with Dissem mycobacterium avium-intracellulare complex (DMAC)

• A31.0 – Pulmonary mycobacterial infection

ICD-10 Code A31.2 in Medical Billing and Insurance for Dissem mycobacterium avium-intracellulare complex (DMAC)

ICD-10 Code A31.2 is critical in billing for hospital, ER, or infectious disease care, ensuring accurate reimbursement for services rendered.

Billing Notes:

• Document all relevant clinical findings and treatment plans to support the claim.
• Use this code in inpatient and outpatient settings where DMAC is diagnosed.
• Ensure that the patient's immunocompromised status is clearly noted in the documentation.

Common CPT Pairings: